Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis

• Prif Awduron: Kalyani Sonawane (Awdur), Tara Castellano (Awdur), Christina Washington (Awdur), Jie Ting (Awdur), Andy Surinach (Awdur), Carol Kirshner (Awdur), Jagpreet Chhatwal (Awdur), Turgay Ayer (Awdur), Kathleen Moore (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2022-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Purpose: Contemporary, real-world data on eligible patients receiving treatment following progression on first-line (1L) recurrent or metastatic cervical cancer (r/mCC) therapy are needed to inform treatment algorithms and identify potential gaps in the r/mCC care continuum. Methods: This study esti...